SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19897852
Source:
http://linkedlifedata.com/resource/pubmed/id/19897852
Search
Subject
(
69
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0036043
,
umls-concept:C0087111
,
umls-concept:C0233820
,
umls-concept:C0278678
,
umls-concept:C0282460
,
umls-concept:C1176020
,
umls-concept:C1556094
pubmed:issue
3
pubmed:dateCreated
2010-3-1
pubmed:abstractText
This study aims to assess the efficacy and safety of sunitinib in Japanese patients with metastatic renal cell carcinoma (RCC).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles
,
http://linkedlifedata.com/resource/pubmed/chemical/sunitinib
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1465-3621
pubmed:author
pubmed-author:AgataNaokiN
,
pubmed-author:AkazaHideyukiH
,
pubmed-author:FujimotoHiroyukiH
,
pubmed-author:HasegawaYoshihiroY
,
pubmed-author:HoukBrettB
,
pubmed-author:MikiTsuneharuT
,
pubmed-author:MugiyaSoichiS
,
pubmed-author:NaitoSeijiS
,
pubmed-author:NiwakawaMasashiM
,
pubmed-author:NonomuraNorioN
,
pubmed-author:ShinoharaNobuoN
,
pubmed-author:TakahashiMasayukiM
,
pubmed-author:TomitaYoshihikoY
,
pubmed-author:UemuraHirotsuguH
,
pubmed-author:YuasaTakeshiT
pubmed:issnType
Electronic
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
194-202
pubmed:meshHeading
pubmed-meshheading:19897852-Adult
,
pubmed-meshheading:19897852-Aged
,
pubmed-meshheading:19897852-Antineoplastic Agents
,
pubmed-meshheading:19897852-Bone Neoplasms
,
pubmed-meshheading:19897852-Carcinoma, Renal Cell
,
pubmed-meshheading:19897852-Female
,
pubmed-meshheading:19897852-Humans
,
pubmed-meshheading:19897852-Indoles
,
pubmed-meshheading:19897852-Japan
,
pubmed-meshheading:19897852-Kidney Neoplasms
,
pubmed-meshheading:19897852-Lung Neoplasms
,
pubmed-meshheading:19897852-Lymphatic Metastasis
,
pubmed-meshheading:19897852-Male
,
pubmed-meshheading:19897852-Middle Aged
,
pubmed-meshheading:19897852-Neoplasm Staging
,
pubmed-meshheading:19897852-Prognosis
,
pubmed-meshheading:19897852-Pyrroles
,
pubmed-meshheading:19897852-Safety
,
pubmed-meshheading:19897852-Survival Rate
,
pubmed-meshheading:19897852-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety.
pubmed:affiliation
Department of Urology, University of Tsukuba, Graduate School of Comprehensive Human Sciences, Tsukuba 305-8576, Japan.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II